Manufacturing Industry

Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis

Chemistry and Industry, August 11, 2008 by Neil Eisberg

Dutch headquartered pharma concern Zentiva, which operates in Central and Eastern Europe, has rejected an unsolicited takeover bid by French pharma major sanofi-aventis. The offer of CZK10S0/share, making Zentiva worth $2.69bn, is said to undervalue the company, and follows an even lower offer by PPF.

Sanofi-aventis already owns just under 25% of Zentiva through the acquisition of a $518m holding in 2006.

COPYRIGHT 2008 Society of Chemical Industry
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale